Immunology/Inflammation
Immunology/Inflammation(免疫及炎症)
The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.
Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].
BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].
Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.
Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].
References
[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.
[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.
[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.
[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.
[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.
[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.
[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.
[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.
- 5-Lipoxygenase(11)
- Papain(1)
- PGDS(1)
- PGE synthase(24)
- SIKs(12)
- IκB/IKK(67)
- AP-1(6)
- KEAP1-Nrf2(65)
- NOD1(1)
- TLR(140)
- NF-κB(241)
- Interleukin Related(171)
- 15-lipoxygenase(2)
- Others(63)
- Aryl Hydrocarbon Receptor(36)
- CD73(14)
- Complement System(58)
- Galectin(12)
- IFNAR(25)
- NO Synthase(77)
- NOD-like Receptor (NLR)(51)
- STING(110)
- Reactive Oxygen Species(465)
- Apoptosis(802)
- FKBP(20)
- eNOS(5)
- iNOS(29)
- nNOS(20)
- Glutathione(57)
- Adaptive Immunity(222)
- Allergy(130)
- Arthritis(34)
- Autoimmunity(190)
- Gastric Disease(101)
- Immunosuppressants(39)
- Immunotherapeutics(5)
- Innate Immunity(593)
- Pulmonary Diseases(119)
- Reactive Nitrogen Species(55)
- Reactive Sulfur Species(28)
- Specialized Pro-Resolving Mediators(50)
- Cyclic GMP-AMP Synthase(2)
- BCL6(3)
- CD20(3)
- CD22
- CD28(1)
- FAP(7)
- PSMA(7)
- Nuclear Factor of activated T Cells (NFAT)(1)
- Glycoprotein VI(1)
- Tim3(2)
- Hapten(1)
- Nectin-4(2)
Immunology/Inflammation 相关产品(4245)
- GC65555PROTAC FLT-3 degrader 1CAS: 2230826-81-8纯度: >98.00%
PROTAC FLT-3 degrader 1 是基于 von Hippel-Lindau 的 FLT-3内部串联重复 (ITD) 降解剂 PROTAC,IC50为0.6 nM。抗增殖,诱导凋亡活性。
- GC65556HomomangiferinCAS: 21794-66-1
Homomangiferin 是一种芒果苷单甲醚。Homomangiferin 具有重要的药用特性,广泛用于缓解许多症状,如咳嗽和哮喘。
- GC65565CyproheptadineCAS: 129-03-3纯度: >99.50%
Cyproheptadine HCl(Periactin) is a hydrochloride salt form of cyproheptadine which is a histamine receptor antagonist.
- GC65610(R)-5-Hydroxy-1,7-diphenyl-3-heptanoneCAS: 100761-20-4纯度: >99.00%
(R)-5-Hydroxy-1,7-diphenyl-3-heptanone 是一种二芳基庚烷,存在于 Alpinia officinarum 中。(R)-5-Hydroxy-1,7-diphenyl-3-heptanone 通过激活 Nrf2/ARE 通路改善氧化应激和胰岛素抵抗。
- GC65915TLR7/8 agonist 4CAS: 2388520-33-8
TLR7/8 agonist 4 (compound 41) 是一种有效的 TLR7/8 激动剂。TLR7/8 agonist 4 具有抗癌活性。
- GC65924Lipopolysaccharides纯度: {{1-12,15}Po->3000000 EU/mg / {13}Po->>500000 EU/mg / {14}Po->40000000 EU/mg} / {16}Po->15000000 EU/mg}
Lipopolysaccharides (LPS) 脂多糖是从革兰氏阴性菌外膜的外叶中提取的内毒素,由一个抗原 O- 特异性链、一个核心寡糖和脂质 A 构成。Lipopolysaccharides 是一种激活免疫系统的致病相关分子模式 (PAMP)。Lipopolysaccharides 激活免疫细胞的 TLR-4。 本产品来源于大肠杆菌 O55:B5。
- GC65995NOD2 antagonist 1CAS: 2411441-54-6纯度: >99.50%
NOD2 antagonist 1 (compound 32) 是一种有效且具有选择性的 NOD2 拮抗剂,IC50 为 5.23 μM。NOD2 antagonist 1 可在 THP-1 细胞中抑制 Muramyl dipeptide (MDP) 诱导的 IL-8 分泌,也在 PBMCs 细胞中抑制 MDP 诱导的 IL-6、IL-10 和 TNF-α 的水平升高。
- GC66008STING agonist-7纯度: >97.00%
STING agonist-7 是一种非核苷酸 STING 激动剂,选择性结合小鼠 STING 而不是人类 STING。STING agonist-7 穿透细胞膜较差。
- GC66054Nrf2 activator-4CAS: 2383016-68-8纯度: >98.00%
Nrf2 activator-4 (Compound 20a) 是一种高效的、具有口服活性的 Nrf2 激活剂,EC50 值为 0.63 µM。Nrf2 activator-4 抑制小神经胶质细胞中活性氧 (reactive oxygen species) 的产生。Nrf2 activator-4 在 scopolamine 诱导的小鼠模型中能有效地恢复学习和记忆损伤。
- GC66328CanakinumabCAS: 914613-48-2纯度: >99.00%
Canakinumab (ACZ885) 是一种重组的人抗 IL-1β 单克隆抗体。Canakinumab 显示出对人类和绒猴 IL-1β 的 IC50 值为分别为 43.6 和 40.8 pM。Canakinumab 的作用模式是基于对 IL-1β 信号的中和,从而抑制与自身免疫性疾病相关的炎症。
- GC66331BasiliximabCAS: 179045-86-4
Basiliximab (CHI 621) 是一种重组嵌合鼠/人 IgG1 单克隆抗白细胞介素 2 受体 (interleukin-2 receptor) 抗体。Basiliximab 可用于肾移植研究。
- GC66334(Rac)-PF-184 hydrate纯度: >98.00%
(Rac)-PF-184 hydrate 是一种有效的 inhibitory factor-κB kinase 2 (IKK-2) 抑制剂,IC50 值为 37 nM。(Rac)-PF-184 hydrate 具有抗炎作用。
- GC66342SatralizumabCAS: 1535963-91-7
Satralizumab 是一种人源化单克隆抗体,是一种有效的白细胞介素 -6 (IL-6) 抑制剂。Satralizumab 可防止褐家鼠的 dTAA 形成和发展。Satralizumab 可用于视神经脊髓炎 (NMOSD) 和降胸主动脉动脉瘤 (dTAA) 的研究。
- GC66343n-Butyl-β-D-fructofuranosideCAS: 80971-60-4纯度: >97.00%
n-Butyl-β-D-fructofuranoside 可以从 kangaisan 中分离出来。n-Butyl-β-D-fructofuranoside 通过线粒体途径诱导细胞凋亡。n-Butyl-β-D-fructofuranoside 可用于癌症研究。
- GC66347MepolizumabCAS: 196078-29-2
Mepolizumab (SB 240563) 是一种人源化的单克隆抗体,可结合并中和白细胞介素 5 (IL-5),白细胞介素 5 (IL-5) 是参与嗜酸性粒细胞增殖、活化和存活的主要细胞因子。Mepolizumab 可用于嗜酸性肉芽肿伴多血管炎 (EGPA) 和重度嗜酸性哮喘的研究。
- GC66348SutimlimabCAS: 2049079-64-1纯度: >95.00%
Sutimlimab 是首创的补体蛋白成分 1,s 亚成分 (C1s)抑制剂,可用于冷凝集素综合征的研究。C1s 是一种丝氨酸蛋白酶,可切割 C4 和 C2 以形成 C3 转化酶。
- GC66350TralokinumabCAS: 1044515-88-9
Tralokinumab 是一种全人源 IgG4 单克隆抗体,可与单独的 IL-13 以高亲和力特异性结合,防止其与受体相互作用和随后的下游信号传导。Tralokinumab 可用于特应性皮炎 (AD) 的研究。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC65555 | PROTAC FLT-3 degrader 1 | 2230826-81-8 | >98.00% | |
PROTAC FLT-3 degrader 1 是基于 von Hippel-Lindau 的 FLT-3内部串联重复 (ITD) 降解剂 PROTAC,IC50为0.6 nM。抗增殖,诱导凋亡活性。 | ||||
| GC65556 | Homomangiferin | 21794-66-1 | - | |
Homomangiferin 是一种芒果苷单甲醚。Homomangiferin 具有重要的药用特性,广泛用于缓解许多症状,如咳嗽和哮喘。 | ||||
| GC65565 | Cyproheptadine | 129-03-3 | >99.50% | |
Cyproheptadine HCl(Periactin) is a hydrochloride salt form of cyproheptadine which is a histamine receptor antagonist. | ||||
| GC65588 | GB1211 | 1978336-95-6 | - | |
GB1211 是一种具有口服活性的 galectin-3 (Gal-3) 抑制剂。 | ||||
| GC65610 | (R)-5-Hydroxy-1,7-diphenyl-3-heptanone | 100761-20-4 | >99.00% | |
(R)-5-Hydroxy-1,7-diphenyl-3-heptanone 是一种二芳基庚烷,存在于 Alpinia officinarum 中。(R)-5-Hydroxy-1,7-diphenyl-3-heptanone 通过激活 Nrf2/ARE 通路改善氧化应激和胰岛素抵抗。 | ||||
| GC65915 | TLR7/8 agonist 4 | 2388520-33-8 | - | |
TLR7/8 agonist 4 (compound 41) 是一种有效的 TLR7/8 激动剂。TLR7/8 agonist 4 具有抗癌活性。 | ||||
| GC65924 | Lipopolysaccharides | - | {{1-12,15}Po->3000000 EU/mg / {13}Po->>500000 EU/mg / {14}Po->40000000 EU/mg} / {16}Po->15000000 EU/mg} | |
Lipopolysaccharides (LPS) 脂多糖是从革兰氏阴性菌外膜的外叶中提取的内毒素,由一个抗原 O- 特异性链、一个核心寡糖和脂质 A 构成。Lipopolysaccharides 是一种激活免疫系统的致病相关分子模式 (PAMP)。Lipopolysaccharides 激活免疫细胞的 TLR-4。 本产品来源于大肠杆菌 O55:B5。 | ||||
| GC65930 | Vitamin K3-d8 | 478171-80-1 | - | |
Vitamin K3-d8 是 Vitamin K3 的氘代物。 | ||||
| GC65995 | NOD2 antagonist 1 | 2411441-54-6 | >99.50% | |
NOD2 antagonist 1 (compound 32) 是一种有效且具有选择性的 NOD2 拮抗剂,IC50 为 5.23 μM。NOD2 antagonist 1 可在 THP-1 细胞中抑制 Muramyl dipeptide (MDP) 诱导的 IL-8 分泌,也在 PBMCs 细胞中抑制 MDP 诱导的 IL-6、IL-10 和 TNF-α 的水平升高。 | ||||
| GC66004 | K67 | 2046250-48-8 | - | |
K67 特异性抑制 Keap1 和 S349磷酸化 p62 之间的相互作用。K67 抑制 p-p62 与 Keap1 的竞争性结合,通过恢复 Keap1 驱动的 Nrf2 泛素化降解,有效抑制高表达S351磷酸化 p62 的 HCC 细胞的增殖。 | ||||
| GC66008 | STING agonist-7 | - | >97.00% | |
STING agonist-7 是一种非核苷酸 STING 激动剂,选择性结合小鼠 STING 而不是人类 STING。STING agonist-7 穿透细胞膜较差。 | ||||
| GC66019 | MLN120B dihydrochloride | 1782573-78-7 | >99.00% | |
An IKKβ inhibitor | ||||
| GC66054 | Nrf2 activator-4 | 2383016-68-8 | >98.00% | |
Nrf2 activator-4 (Compound 20a) 是一种高效的、具有口服活性的 Nrf2 激活剂,EC50 值为 0.63 µM。Nrf2 activator-4 抑制小神经胶质细胞中活性氧 (reactive oxygen species) 的产生。Nrf2 activator-4 在 scopolamine 诱导的小鼠模型中能有效地恢复学习和记忆损伤。 | ||||
| GC66328 | Canakinumab | 914613-48-2 | >99.00% | |
Canakinumab (ACZ885) 是一种重组的人抗 IL-1β 单克隆抗体。Canakinumab 显示出对人类和绒猴 IL-1β 的 IC50 值为分别为 43.6 和 40.8 pM。Canakinumab 的作用模式是基于对 IL-1β 信号的中和,从而抑制与自身免疫性疾病相关的炎症。 | ||||
| GC66331 | Basiliximab | 179045-86-4 | - | |
Basiliximab (CHI 621) 是一种重组嵌合鼠/人 IgG1 单克隆抗白细胞介素 2 受体 (interleukin-2 receptor) 抗体。Basiliximab 可用于肾移植研究。 | ||||
| GC66334 | (Rac)-PF-184 hydrate | - | >98.00% | |
(Rac)-PF-184 hydrate 是一种有效的 inhibitory factor-κB kinase 2 (IKK-2) 抑制剂,IC50 值为 37 nM。(Rac)-PF-184 hydrate 具有抗炎作用。 | ||||
| GC66339 | ODN 2216 | 332437-00-0 | >98.00% | |
ODN 2216 是一种 TLR9 (toll 样受体 9) 配体或激动剂。ODN 2216 诱导大量的 IFN-α 和 IFN-β。ODN 2216 通过 pDC (浆细胞样 DC) 诱导 IFN-α,并通过 DC (树突状细胞)产生 IL-12 (p40)。ODN 2216 刺激外周血单核细胞 (PBMC) 产生 IFN-γ,这是间接的和由 IFN-α/β 介导的。ODN 2216 可以激活 NK 细胞,促进 IFN-γ 产生 TCR 触发的 CD4+ T 细胞。 | ||||
| GC66341 | ODN 2088 | 1146541-45-8 | >90.00% | |
ODN 2088 是一种有效的 TLR3,TLR7 和 TLR9 抑制剂。ODN 2088 没有细胞毒性。ODN 2088 抑制 IFN-α 和 IL-6 的释放。 | ||||
| GC66342 | Satralizumab | 1535963-91-7 | - | |
Satralizumab 是一种人源化单克隆抗体,是一种有效的白细胞介素 -6 (IL-6) 抑制剂。Satralizumab 可防止褐家鼠的 dTAA 形成和发展。Satralizumab 可用于视神经脊髓炎 (NMOSD) 和降胸主动脉动脉瘤 (dTAA) 的研究。 | ||||
| GC66343 | n-Butyl-β-D-fructofuranoside | 80971-60-4 | >97.00% | |
n-Butyl-β-D-fructofuranoside 可以从 kangaisan 中分离出来。n-Butyl-β-D-fructofuranoside 通过线粒体途径诱导细胞凋亡。n-Butyl-β-D-fructofuranoside 可用于癌症研究。 | ||||
| GC66347 | Mepolizumab | 196078-29-2 | - | |
Mepolizumab (SB 240563) 是一种人源化的单克隆抗体,可结合并中和白细胞介素 5 (IL-5),白细胞介素 5 (IL-5) 是参与嗜酸性粒细胞增殖、活化和存活的主要细胞因子。Mepolizumab 可用于嗜酸性肉芽肿伴多血管炎 (EGPA) 和重度嗜酸性哮喘的研究。 | ||||
| GC66348 | Sutimlimab | 2049079-64-1 | >95.00% | |
Sutimlimab 是首创的补体蛋白成分 1,s 亚成分 (C1s)抑制剂,可用于冷凝集素综合征的研究。C1s 是一种丝氨酸蛋白酶,可切割 C4 和 C2 以形成 C3 转化酶。 | ||||
| GC66350 | Tralokinumab | 1044515-88-9 | - | |
Tralokinumab 是一种全人源 IgG4 单克隆抗体,可与单独的 IL-13 以高亲和力特异性结合,防止其与受体相互作用和随后的下游信号传导。Tralokinumab 可用于特应性皮炎 (AD) 的研究。 | ||||
| GC66354 | Ezetimibe-d4-1 | 1093659-89-2 | - | |
An internal standard for the quantification of ezetimibe | ||||
